Adverse Event Management

Latest News

VR headset holographic low poly wireframe vector banner. Polygonal man wearing virtual reality glasses, helmet. VR games playing. Particles, dots, lines, triangles on blue background. Neon light.: © matrosovv - stock.adobe.com
Virtual Reality Is a Tool for Education, Relaxation for Nurses and Patients

February 13th 2024

Virtual reality headsets can be used to reduce anxiety in patients with cancer undergoing treatment and as an educational tool for nurses learning how to have difficult conversations with patients.

Holographic concept of lung cancer display, lung disease, treatment of lung cancer, lung illness such as pneumonia, viral infections or cancer 3d rendering | Image Credit: © catalin - stock.adobe.com
T-Cell Engagers Take Center Stage in Large B-Cell Lymphoma

February 12th 2024

Young tired manager sitting in restaurant surrounded with papers and laptop computer having tired look holding his hand on neck having pain closing his eyes being sleepy and exhausted. Tiredness: © Wayhome Studio - stock.adobe.com
Navigating Difficult Conversations in Cancer Pain Management

February 9th 2024

Lower-Dose Olanzapine Noninferior to Standard Dose to Control Nausea/Vomiting in Patients With Solid Tumors Receiving Chemo
Lower-Dose Olanzapine Noninferior to Standard Dose to Control Nausea/Vomiting in Patients With Solid Tumors Receiving Chemo

February 6th 2024

ERBT Before Ra-223 May Not Increase Hematological Toxicity in mCRPC
ERBT Before Ra-223 May Not Increase Hematological Toxicity in mCRPC

January 26th 2024

Video Interviews
Podcasts
Bringing a New Approach to Symptom Management in Ovarian Cancer
The Vitals - Oncology Nursing News
Latest CME Events & Activities

Dialogues with the Surgeon on Integration of Systemic Therapies in Perioperative Settings for NSCLC: What Do Current Data for IO- and ALK-Targeted Strategies Tell Us?

March 19, 2024

Register Now!

Optimizing Pain Management for Breast Cancer Surgery Patients in the Age of the Opioid Epidemic

View More

Medical Crossfire®: Why is PSMA so Effective? To Affinity and Beyond

View More

The Latest on Acute Lymphocytic Leukemia

View More

A Focus on Acute Myeloid Leukemia

View More

Updates in Myelodysplastic Syndromes

View More

Community Practice Connections™: What’s Next for Patients with Breast Cancer, and How Can We Effectively Optimize PARP-, HER2/3-, and TROP2-Targeted Regimens in Treatment Plans?

View More

Patient, Provider and Caregiver Connection™: Addressing Patient Concerns During the Treatment and Management of HR+/HER2- Breast Cancer

View More

Breaking Down Biomarkers in Non–Small Cell Lung Cancer: A Case-Based Discussion for the Oncology Nurse

View More

Medical Crossfire®: Critical Questions on Diagnosis, Sequencing, and Selection of Systemic and Radioligand Therapy Options for Patients with GEP-NETs

View More

Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy

View More

Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma

View More

Go To PER in Chicago

May 31, 2024 - June 2, 2024

Register Now!

The Top 10 Oncogenic Drivers in NSCLC for 2023: What You Need to Know on Tumor Testing, Targets, and Treatment Strategies to Move the Field Forward

View More

Oncology Consultations®: Next Generation SERDs—Key Data and Practical Takeaways for the Community Physician

View More

Everything You Need to Know About PARP Inhibitor Combinations in Prostate Cancer Care: Why? For Whom? And When?

View More

Medical Crossfire®: Leveraging Multidisciplinary Teams in Early–Stage Breast Cancer When the Goal is Cure

View More

Expanding the Armamentarium of Actionable Mutations in NSCLC: Uncovering the Potential of CEACAM5 as a Therapeutic Target

View More

Multidisciplinary Management of TNBC: Immunotherapy, PARP, TROP2, Oh My!

View More

23rd Annual International Congress on the Future of Breast Cancer® East

July 19-20, 2024

Register Now!

Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies

View More

Advances In™: Targeting PSMA to Advance Diagnosis And Management Of Patients With Prostate Cancer

View More

Clinical Case Vignette Series: Integrating Recent Data into Practice to Improve Outcomes in Advanced Prostate Cancer

View More

Community Practice Connections™: 8th Annual School of Gastrointestinal Oncology®

View More

Community Practice Connections™: The Advent of TROP2-Targeted Treatment Approaches in HR+/HER2- Breast Cancer

View More

Show Me the Data™: Do We Have Sea Change for Novel Approaches in HR+/HER2- Breast Cancer? CDK, PI3K/AKT, ADC, and Next-Gen SERD Strategies Assessed

View More

Community Practice Connections™: Controversies and Conversations About HER2- Expressing Breast Cancer…Advances in Management of HER2-Low to -Positive Disease

View More

Cancer Summaries and Commentaries™: Clinical Updates from Chicago in Breast Cancer

View More

8th Annual School of Nursing Oncology™

August 10, 2024

Register Now!

Pathology Implications for CEACAM5 as a Therapeutic Target in Advanced NSCLC

View More

More News

© 2024 MJH Life Sciences

All rights reserved.